VIRUSLI GEPATIT BILAN KASALLANGAN TUG‘ISH YOSHIDAGI AYOLLARDA BIOKIMYOVIY MARKERLARNING DIAGNOSTIK AHAMIYATI
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstrak:
Virusli gepatit jahon sog‘liqni saqlash tizimi oldida eng dolzarb muammolardan biri bo‘lib qolmoqda. Xalqaro statistik ma’lumotlarga ko‘ra, dunyo bo‘yicha 350 milliondan ortiq odam surunkali gepatit B tashuvchisi hisoblanadi, 71 milliondan ziyod odam esa gepatit C virusi bilan zararlangan (WHO, 2023). Ayniqsa, tug‘ish yoshidagi ayollar orasida ushbu kasalliklarning yuqori darajada uchrashi, ularning sog‘lig‘iga va kelajak avlodning rivojlanishiga bevosita ta’sir ko‘rsatadi. Virusli gepatitning klinik oqibatlari jigar sirrozi, jigar yetishmovchiligi va gepatosellyulyar karsinoma rivojlanishi bilan cheklanmaydi. Reproduktiv yoshdagi ayollarda kasallik homiladorlik davrida bir qator asoratlar – homilaning intrauterin infeksiyalanishi, muddatidan oldin tug‘ilish, o‘lik tug‘ilish, bola vaznining kam bo‘lishi – xavfini oshiradi.
##plugins.themes.bootstrap3.article.details##
##submission.howToCite##:
##submission.citations##:
World Health Organization. (2023). Global progress report on HIV, viral hepatitis and sexually transmitted infections. WHO.
European Association for the Study of the Liver (EASL). (2022). Clinical Practice Guidelines on hepatitis B and C. Journal of Hepatology, 76(4), 959–1010.
Terrault N. A., et al. (2021). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 67(4), 1560–1599.
Lok A. S., & McMahon B. J. (2020). Chronic hepatitis B. New England Journal of Medicine, 382(4), 353–361.
Blach S., et al. (2021). Global prevalence and genotype distribution of hepatitis C virus infection in 2020. Journal of Hepatology, 74(2), 212–224.
Schweitzer A., et al. (2020). Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data. Lancet, 386(10003), 1546–1555.
Terrault N. A. (2019). Reproductive health in women with hepatitis B and C. Journal of Clinical Gastroenterology, 53(3), 179–185.
WHO Regional Office for Europe. (2022). Hepatitis elimination goals and maternal health.